Techniques in Vascular & Interventional Radiology
Volume 9, Issue 3 , Pages 90-95 , September 2006

Practice Building in Interventional Oncology

  • Daniel B. Brown, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Daniel B. Brown, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, Box 8131, Saint Louis, MO 63110.
    • ,
  • Jennifer E. Gould, MD

References 

  1. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  2. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet. 2002;359:1734–1739
  3. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–1129
  4. Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: Variables affecting response rates and survival. Cancer. 2005;104:1590–1602
  5. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–2351
  6. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129:738–745
  7. Chrisman HB, Basu PA, Omary RA. The positive effect of targeted marketing on an existing uterine fibroid embolization practice. JVIR. 2006;17:577–581

PII: S1089-2516(07)00004-2

doi: 10.1053/j.tvir.2007.01.003

Techniques in Vascular & Interventional Radiology
Volume 9, Issue 3 , Pages 90-95 , September 2006

Article Tools

* Image Usage & Resolution